Snowball logo
logo
PGZ

Healius Limited

€0.262+€0.008  (3.15%)
Estimate
EPS
-0.35
Beta
0.291
About the company
Ticker
PGZ
ISIN
AU0000033359
Country
Australia
Sector (GICS)
Healthcare
Healius Limited provides medical laboratory and pathology services in Australia. The company provides services under the Laverty Pathology, Dorevitch Pathology, QML Pathology, Western Diagnostic Pathology, Genomic Diagnostic, Vetnostics Pathology, QML Pathology, TML Pathology, Abbott Pathology, IQ Pathology, Kossard, Gastrolab, and Agilex Biolabs brands. It operates medical laboratories and patient collection centers. The company was formerly known as Primary Health Care Limited and changed its name to Healius Limited in December 2018. Healius Limited was incorporated in 1994 and is based in Sydney, Australia.

Frequently asked questions

What sector does Healius Limited (PGZ) operate in?

Healius Limited belongs to the Healthcare sector and operates in the Diagnostics & Research industry.

What is Healius Limited (PGZ) current stock price?

As of the latest data, Healius Limited stock price is €0.26, with a previous close of €0.25. Healius Limited gained €0.01 in the last trading session, representing a 3.15% increase.

What is Healius Limited (PGZ) current market capitalization?

Healius Limited market cap is approximately 190.26 million.

What is Healius Limited (PGZ) Earnings Per Share (EPS)?

The trailing EPS is -€0.35.

Does Healius Limited (PGZ) pay dividends?

No. Healius Limited does not pay a dividend.

When is Healius Limited (PGZ) next earnings report?

Healius Limited is expected to release its next earnings report on December 31, 2026.

What is Healius Limited (PGZ) beta (volatility) score?

Healius Limited has a beta of 0.291, indicating lower volatility than the overall market.